Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin Cement, bone DePuy CMW, Blackpool, United Kingdom CMW 1 Gentamicin Bone Cement Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin Cement, bone DePuy CMW, Blackpool, United Kingdom CMW 3 Gentamicin Bone Cement Raloxifene hydrochloride 60 mg equivalent to 56 mg raloxifene Tablet, film coated Eli Lilly & Company Limited, Basingstoke, Hampshire, England; and Lilly del Caribe Inc., Carolina, Puerto Rico Evista Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin Cement, bone DePuy CMW, Blackpool, United Kingdom Vacu-Mix Plus (with CMW 1 Gentamicin Bone Cement) Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin Cement, bone DePuy CMW, Blackpool, United Kingdom Vacu-Mix Plus (with CMW 3 Gentamicin Bone Cement) Dated this 23rd day of February 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.